| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |